Global Tumor Diagnosis Solutions Market 2025 by Company, Regions, Type and Application, Forecast to 2031

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Tumor Diagnosis Solutions by Type
  • 1.3.1 Overview: Global Tumor Diagnosis Solutions Market Size by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Global Tumor Diagnosis Solutions Consumption Value Market Share by Type in 2024
  • 1.3.3 Lung Cancer Diagnostic Services
  • 1.3.4 Breast Cancer Diagnostic Services
  • 1.3.5 Kidney Cancer Diagnostic Services
  • 1.3.6 Other
• 1.4 Global Tumor Diagnosis Solutions Market by Application
  • 1.4.1 Overview: Global Tumor Diagnosis Solutions Market Size by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Hospital
  • 1.4.3 Clinic
  • 1.4.4 Other
• 1.5 Global Tumor Diagnosis Solutions Market Size & Forecast
• 1.6 Global Tumor Diagnosis Solutions Market Size and Forecast by Region
  • 1.6.1 Global Tumor Diagnosis Solutions Market Size by Region: 2020 VS 2024 VS 2031
  • 1.6.2 Global Tumor Diagnosis Solutions Market Size by Region, (2020-2031)
  • 1.6.3 North America Tumor Diagnosis Solutions Market Size and Prospect (2020-2031)
  • 1.6.4 Europe Tumor Diagnosis Solutions Market Size and Prospect (2020-2031)
  • 1.6.5 Asia-Pacific Tumor Diagnosis Solutions Market Size and Prospect (2020-2031)
  • 1.6.6 South America Tumor Diagnosis Solutions Market Size and Prospect (2020-2031)
  • 1.6.7 Middle East & Africa Tumor Diagnosis Solutions Market Size and Prospect (2020-2031)

2 Company Profiles

• 2.1 Dian Diagnostics Group
  • 2.1.1 Dian Diagnostics Group Details
  • 2.1.2 Dian Diagnostics Group Major Business
  • 2.1.3 Dian Diagnostics Group Tumor Diagnosis Solutions Product and Solutions
  • 2.1.4 Dian Diagnostics Group Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Dian Diagnostics Group Recent Developments and Future Plans
• 2.2 Sansure Biotech
  • 2.2.1 Sansure Biotech Details
  • 2.2.2 Sansure Biotech Major Business
  • 2.2.3 Sansure Biotech Tumor Diagnosis Solutions Product and Solutions
  • 2.2.4 Sansure Biotech Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Sansure Biotech Recent Developments and Future Plans
• 2.3 YHLO Biotech
  • 2.3.1 YHLO Biotech Details
  • 2.3.2 YHLO Biotech Major Business
  • 2.3.3 YHLO Biotech Tumor Diagnosis Solutions Product and Solutions
  • 2.3.4 YHLO Biotech Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 YHLO Biotech Recent Developments and Future Plans
• 2.4 Thermo Fisher Scientific
  • 2.4.1 Thermo Fisher Scientific Details
  • 2.4.2 Thermo Fisher Scientific Major Business
  • 2.4.3 Thermo Fisher Scientific Tumor Diagnosis Solutions Product and Solutions
  • 2.4.4 Thermo Fisher Scientific Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
• 2.5 Amoy Diagnostics
  • 2.5.1 Amoy Diagnostics Details
  • 2.5.2 Amoy Diagnostics Major Business
  • 2.5.3 Amoy Diagnostics Tumor Diagnosis Solutions Product and Solutions
  • 2.5.4 Amoy Diagnostics Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.5.5 Amoy Diagnostics Recent Developments and Future Plans
• 2.6 Ibex
  • 2.6.1 Ibex Details
  • 2.6.2 Ibex Major Business
  • 2.6.3 Ibex Tumor Diagnosis Solutions Product and Solutions
  • 2.6.4 Ibex Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.6.5 Ibex Recent Developments and Future Plans
• 2.7 Elephas
  • 2.7.1 Elephas Details
  • 2.7.2 Elephas Major Business
  • 2.7.3 Elephas Tumor Diagnosis Solutions Product and Solutions
  • 2.7.4 Elephas Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.7.5 Elephas Recent Developments and Future Plans
• 2.8 Philips Healthcare
  • 2.8.1 Philips Healthcare Details
  • 2.8.2 Philips Healthcare Major Business
  • 2.8.3 Philips Healthcare Tumor Diagnosis Solutions Product and Solutions
  • 2.8.4 Philips Healthcare Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.8.5 Philips Healthcare Recent Developments and Future Plans
• 2.9 Lepu Medical
  • 2.9.1 Lepu Medical Details
  • 2.9.2 Lepu Medical Major Business
  • 2.9.3 Lepu Medical Tumor Diagnosis Solutions Product and Solutions
  • 2.9.4 Lepu Medical Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.9.5 Lepu Medical Recent Developments and Future Plans
• 2.10 Epredia
  • 2.10.1 Epredia Details
  • 2.10.2 Epredia Major Business
  • 2.10.3 Epredia Tumor Diagnosis Solutions Product and Solutions
  • 2.10.4 Epredia Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.10.5 Epredia Recent Developments and Future Plans
• 2.11 Roche
  • 2.11.1 Roche Details
  • 2.11.2 Roche Major Business
  • 2.11.3 Roche Tumor Diagnosis Solutions Product and Solutions
  • 2.11.4 Roche Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.11.5 Roche Recent Developments and Future Plans
• 2.12 Caris Life Sciences
  • 2.12.1 Caris Life Sciences Details
  • 2.12.2 Caris Life Sciences Major Business
  • 2.12.3 Caris Life Sciences Tumor Diagnosis Solutions Product and Solutions
  • 2.12.4 Caris Life Sciences Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.12.5 Caris Life Sciences Recent Developments and Future Plans
• 2.13 NeoGenomics
  • 2.13.1 NeoGenomics Details
  • 2.13.2 NeoGenomics Major Business
  • 2.13.3 NeoGenomics Tumor Diagnosis Solutions Product and Solutions
  • 2.13.4 NeoGenomics Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.13.5 NeoGenomics Recent Developments and Future Plans
• 2.14 OncoDNA
  • 2.14.1 OncoDNA Details
  • 2.14.2 OncoDNA Major Business
  • 2.14.3 OncoDNA Tumor Diagnosis Solutions Product and Solutions
  • 2.14.4 OncoDNA Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.14.5 OncoDNA Recent Developments and Future Plans
• 2.15 Kheiron
  • 2.15.1 Kheiron Details
  • 2.15.2 Kheiron Major Business
  • 2.15.3 Kheiron Tumor Diagnosis Solutions Product and Solutions
  • 2.15.4 Kheiron Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.15.5 Kheiron Recent Developments and Future Plans
• 2.16 Abbott
  • 2.16.1 Abbott Details
  • 2.16.2 Abbott Major Business
  • 2.16.3 Abbott Tumor Diagnosis Solutions Product and Solutions
  • 2.16.4 Abbott Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.16.5 Abbott Recent Developments and Future Plans
• 2.17 Mirada Medical
  • 2.17.1 Mirada Medical Details
  • 2.17.2 Mirada Medical Major Business
  • 2.17.3 Mirada Medical Tumor Diagnosis Solutions Product and Solutions
  • 2.17.4 Mirada Medical Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.17.5 Mirada Medical Recent Developments and Future Plans
• 2.18 GuardantHealth
  • 2.18.1 GuardantHealth Details
  • 2.18.2 GuardantHealth Major Business
  • 2.18.3 GuardantHealth Tumor Diagnosis Solutions Product and Solutions
  • 2.18.4 GuardantHealth Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.18.5 GuardantHealth Recent Developments and Future Plans
• 2.19 Labcorp
  • 2.19.1 Labcorp Details
  • 2.19.2 Labcorp Major Business
  • 2.19.3 Labcorp Tumor Diagnosis Solutions Product and Solutions
  • 2.19.4 Labcorp Tumor Diagnosis Solutions Revenue, Gross Margin and Market Share (2020-2025)
  • 2.19.5 Labcorp Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Tumor Diagnosis Solutions Revenue and Share by Players (2020-2025)
• 3.2 Market Share Analysis (2024)
  • 3.2.1 Market Share of Tumor Diagnosis Solutions by Company Revenue
  • 3.2.2 Top 3 Tumor Diagnosis Solutions Players Market Share in 2024
  • 3.2.3 Top 6 Tumor Diagnosis Solutions Players Market Share in 2024
• 3.3 Tumor Diagnosis Solutions Market: Overall Company Footprint Analysis
  • 3.3.1 Tumor Diagnosis Solutions Market: Region Footprint
  • 3.3.2 Tumor Diagnosis Solutions Market: Company Product Type Footprint
  • 3.3.3 Tumor Diagnosis Solutions Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Tumor Diagnosis Solutions Consumption Value and Market Share by Type (2020-2025)
• 4.2 Global Tumor Diagnosis Solutions Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

• 5.1 Global Tumor Diagnosis Solutions Consumption Value Market Share by Application (2020-2025)
• 5.2 Global Tumor Diagnosis Solutions Market Forecast by Application (2026-2031)

6 North America

• 6.1 North America Tumor Diagnosis Solutions Consumption Value by Type (2020-2031)
• 6.2 North America Tumor Diagnosis Solutions Market Size by Application (2020-2031)
• 6.3 North America Tumor Diagnosis Solutions Market Size by Country
  • 6.3.1 North America Tumor Diagnosis Solutions Consumption Value by Country (2020-2031)
  • 6.3.2 United States Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 6.3.3 Canada Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 6.3.4 Mexico Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)

7 Europe

• 7.1 Europe Tumor Diagnosis Solutions Consumption Value by Type (2020-2031)
• 7.2 Europe Tumor Diagnosis Solutions Consumption Value by Application (2020-2031)
• 7.3 Europe Tumor Diagnosis Solutions Market Size by Country
  • 7.3.1 Europe Tumor Diagnosis Solutions Consumption Value by Country (2020-2031)
  • 7.3.2 Germany Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 7.3.3 France Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 7.3.4 United Kingdom Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 7.3.5 Russia Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 7.3.6 Italy Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)

8 Asia-Pacific

• 8.1 Asia-Pacific Tumor Diagnosis Solutions Consumption Value by Type (2020-2031)
• 8.2 Asia-Pacific Tumor Diagnosis Solutions Consumption Value by Application (2020-2031)
• 8.3 Asia-Pacific Tumor Diagnosis Solutions Market Size by Region
  • 8.3.1 Asia-Pacific Tumor Diagnosis Solutions Consumption Value by Region (2020-2031)
  • 8.3.2 China Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 8.3.3 Japan Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 8.3.4 South Korea Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 8.3.5 India Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 8.3.6 Southeast Asia Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 8.3.7 Australia Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)

9 South America

• 9.1 South America Tumor Diagnosis Solutions Consumption Value by Type (2020-2031)
• 9.2 South America Tumor Diagnosis Solutions Consumption Value by Application (2020-2031)
• 9.3 South America Tumor Diagnosis Solutions Market Size by Country
  • 9.3.1 South America Tumor Diagnosis Solutions Consumption Value by Country (2020-2031)
  • 9.3.2 Brazil Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 9.3.3 Argentina Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)

10 Middle East & Africa

• 10.1 Middle East & Africa Tumor Diagnosis Solutions Consumption Value by Type (2020-2031)
• 10.2 Middle East & Africa Tumor Diagnosis Solutions Consumption Value by Application (2020-2031)
• 10.3 Middle East & Africa Tumor Diagnosis Solutions Market Size by Country
  • 10.3.1 Middle East & Africa Tumor Diagnosis Solutions Consumption Value by Country (2020-2031)
  • 10.3.2 Turkey Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 10.3.3 Saudi Arabia Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)
  • 10.3.4 UAE Tumor Diagnosis Solutions Market Size and Forecast (2020-2031)

11 Market Dynamics

• 11.1 Tumor Diagnosis Solutions Market Drivers
• 11.2 Tumor Diagnosis Solutions Market Restraints
• 11.3 Tumor Diagnosis Solutions Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Tumor Diagnosis Solutions Industry Chain
• 12.2 Tumor Diagnosis Solutions Upstream Analysis
• 12.3 Tumor Diagnosis Solutions Midstream Analysis
• 12.4 Tumor Diagnosis Solutions Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source